Charles N York Ii Day One Biopharmaceuticals, Inc. (DAWN) insider trading activity

DAWN Quotes by TradingView

Charles N York Ii is COO, CFO AND SECRETARY of Day One Biopharmaceuticals, Inc.. Currently has a direct ownership of 240,133 shares of DAWN, which is worth approximately $3.27 Million. The most recent transaction as insider was on Nov 18, 2024, when has been sold 2,602 shares (Common Stock) at a price of $13.21 per share, resulting in proceeds of $34,372. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 240K
3.29% 3M change
11.12% 12M change
Total Value Held $3.27 Million

Charles N York II Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 18 2024
SELL
Open market or private sale
$34,372 $13.21 p/Share
2,602 Reduced 1.07%
240,133 Common Stock
Nov 15 2024
BUY
Exercise of conversion of derivative security
-
10,250 Added 4.05%
242,735 Common Stock
Aug 16 2024
SELL
Open market or private sale
$36,862 $14.0 p/Share
2,633 Reduced 1.12%
232,485 Common Stock
Aug 15 2024
BUY
Exercise of conversion of derivative security
-
10,250 Added 4.18%
235,118 Common Stock
May 16 2024
SELL
Open market or private sale
$43,013 $16.08 p/Share
2,675 Reduced 1.18%
224,868 Common Stock
May 15 2024
BUY
Exercise of conversion of derivative security
-
10,250 Added 4.31%
227,543 Common Stock
May 03 2024
SELL
Open market or private sale
$144,192 $17.85 p/Share
8,078 Reduced 3.58%
217,293 Common Stock
May 02 2024
SELL
Open market or private sale
$3,579 $17.9 p/Share
200 Reduced 0.09%
225,371 Common Stock
May 01 2024
SELL
Open market or private sale
$933,553 $17.89 p/Share
52,183 Reduced 18.79%
225,571 Common Stock
Feb 16 2024
SELL
Open market or private sale
$40,656 $15.25 p/Share
2,666 Reduced 0.95%
277,754 Common Stock
Feb 15 2024
BUY
Exercise of conversion of derivative security
-
10,250 Added 3.53%
280,420 Common Stock
Nov 16 2023
SELL
Open market or private sale
$11,175 $11.69 p/Share
956 Reduced 0.35%
270,170 Common Stock
Nov 15 2023
BUY
Exercise of conversion of derivative security
-
3,625 Added 1.32%
271,126 Common Stock
Aug 17 2023
SELL
Open market or private sale
$12,778 $13.86 p/Share
922 Reduced 0.34%
267,501 Common Stock
Aug 15 2023
BUY
Exercise of conversion of derivative security
-
3,625 Added 1.33%
268,423 Common Stock
May 16 2023
SELL
Open market or private sale
$12,529 $13.12 p/Share
955 Reduced 0.36%
264,798 Common Stock
May 15 2023
BUY
Exercise of conversion of derivative security
-
3,625 Added 1.35%
265,753 Common Stock
Feb 17 2023
SELL
Open market or private sale
$187,821 $20.03 p/Share
9,377 Reduced 3.45%
262,128 Common Stock
Feb 16 2023
SELL
Open market or private sale
$18,200 $19.57 p/Share
930 Reduced 0.34%
271,505 Common Stock
Feb 15 2023
BUY
Exercise of conversion of derivative security
-
3,625 Added 1.31%
272,435 Common Stock
Jan 20 2023
SELL
Open market or private sale
$227,500 $22.75 p/Share
10,000 Reduced 3.59%
268,810 Common Stock
Dec 20 2022
SELL
Open market or private sale
$200,700 $20.07 p/Share
10,000 Reduced 3.49%
276,497 Common Stock
Nov 21 2022
SELL
Open market or private sale
$210,700 $21.07 p/Share
10,000 Reduced 3.37%
286,497 Common Stock
Nov 16 2022
SELL
Open market or private sale
$9,227 $21.46 p/Share
430 Reduced 0.14%
296,497 Common Stock
Nov 15 2022
BUY
Exercise of conversion of derivative security
-
1,375 Added 0.46%
295,776 Common Stock
CNY

Charles N York Ii

COO, CFO AND SECRETARY
South San Francisco, CA

Track Institutional and Insider Activities on DAWN

Follow Day One Biopharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DAWN shares.

Notify only if

Insider Trading

Get notified when an Day One Biopharmaceuticals, Inc. insider buys or sells DAWN shares.

Notify only if

News

Receive news related to Day One Biopharmaceuticals, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on DAWN